课题基金 / 基金详情

SBIR Phase I: Extraordinary Electroconductance Label-Free Breast Cancer Arrays

SBIR Phase I: Extraordinary Electroconductance Label-Free Breast Cancer Arrays
SBIR 第一阶段:非凡的电导无标记乳腺癌阵列
批准号:
1215176
负责人:
Renee Carder
金额:
$15.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2013-06-30

项目摘要

项目成果

Renee Carder的其他基金

相似基金

相关文献

中文摘要
翻译
这个小型企业创新研究(SBIR)第一阶段项目开发了一个原型基因表达平台,用于准确的癌症诊断、预后和治疗监测。目前的平台有许多局限性,包括缓慢、复杂、劳动密集型的过程;以及次优的灵敏度。与现有的多变量基因表达分析相比,建议的设备将1)提供类似或更好的净灵敏度,2)没有标记,3)提供更小的阵列元素的灵活性,以及4)与竞争技术相比制造成本更低。该传感器采用新颖、专有的金属-半导体混合结构,对外部电场表现出极强的敏感性。与其他可作为阵列传感器部署的电场检测设备相比,传感器设备几何结构已被证明具有更高的灵敏度和更低的噪声。目标是开发初始原型的基本组件,该原型能够以高空间分辨率对与核酸碱基配对有关的单个离子事件进行成像;测试在复杂背景下检测的动态范围和限度,在这种背景下,目标序列存在于相对较大的非互补核酸过剩范围内;以及验证和基准12像素阵列,以用于乳腺癌和正常人乳腺癌和乳腺癌核糖核酸中的参考基因。该项目更广泛的影响/商业潜力集中在全球脱氧核糖核酸和基因芯片市场,预计到2015年该市场将达到14.252亿美元。基因表达产品在临床诊断、生物防御和农业等领域有着广泛的用途。预计到2015年,癌症诊断和治疗应用程序将主导应用程序市场;约占市场份额的24%。拟议的技术优于目前的基因表达分析,在灵敏度、特异性和阵列格式方面提供了显著的改进,并有望将特征大小驱动到纳米级区域-所有这些都是无标记的格式。无标签格式消除了耗时的化学标记;不需要大功率激发源以及复杂的扫描仪器;以及潜在的结果偏差。随着灵敏度和特异度的显著提高,可以使用更小的样本和/或更少的处理;并且,一些更有趣的低拷贝数的生物标志物可以可靠地使用。在不影响敏感性和特异性的情况下实现这种超高分辨率的潜在优势包括将几个与癌症相关的预测性生物标志物整合到单一诊断测试中的能力。因为所提出的传感器是用传统方法生产的,所以它们可以经济地作为高密度阵列来生产。
英文摘要
This Small Business Innovation Research (SBIR) Phase I project develops a prototype gene expression platform for accurate cancer diagnosis, prognosis and treatment monitoring. Current platforms have many limitations, including slow, complex, labor-intensive processes; and suboptimal sensitivity. The proposed device will 1) provide similar or better net sensitivity compared to existing multivariate gene-expression assays, 2) is free of labels; 3) offers the flexibility of much smaller array elements; and, 4) is manufactured inexpensively compared to competing technologies. The sensor uses novel, proprietary, metal-semiconductor hybrid structures that exhibit strongly enhanced sensitivity to external electric fields. The sensor device geometry has been shown to have much higher sensitivity and lower noise than other electric field detection devices that are deployable as array-based sensors. The objectives are to develop the essential components of an initial prototype that is able to image, with high spatial resolution, individual ionic events associated with nucleic acid base pairing; test the dynamic range and limits of detection in a complex background, where the target sequence is present within a relatively large excess of non-complimentary nucleic acids; and, validate and benchmark a 12-pixel array for breast cancer and reference genes in normal human breast and breast cancer ribonucleic acid. The broader impact/commercial potential of this project centers on the global deoxyribonucleic acid and gene chip market, which is expected to reach $1,425.2 million by 2015. Gene expression products have diverse usage in areas such as clinical diagnostics, biodefense, and agriculture. Cancer diagnosis and treatment application is expected to dominant the applications market through 2015; accounting for about a 24% market share. The proposed technology excels over current gene expression assays, offering significant improvements in sensitivity, specificity and an array format, with the promise of driving feature sizes into the nanoscale regime - all in a label-free format. The label-free format eliminates time-consuming chemical labeling; the need for high power excitation sources as well as sophisticated scanning instrumentation; and, potential biasing of results. With significantly improved sensitivity and specificity smaller samples can be used and/or less processing will be required; and, some of the more interesting biomarkers with low copy number can be reliably used. The potential advantages of achieving such ultra-high resolution without compromising sensitivity and specificity include the ability to consolidate several predictive cancer-related biomarkers into a single diagnostic test. Because the proposed sensors are produced using traditional methods, they can be economically produced as high-density arrays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SBIR Phase II: Advancing Beyond the Photodiode - Deep Sub-micron Pixels for Next-generation Image Sensors
  • 批准号:
    1660145
  • 项目类别:
    Standard Grant
  • 资助金额:
    $75.0万
  • 财政年份:
    2017
  • 负责人:
    Renee Carder
  • 依托单位:
STTR Phase I: Advancing Beyond the Photodiode - Deep Sub-micron Pixels for Next-generation Image Sensors
  • 批准号:
    1449019
  • 项目类别:
    Standard Grant
  • 资助金额:
    $22.5万
  • 财政年份:
    2015
  • 负责人:
    Renee Carder
  • 依托单位:
国内基金
海外基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YUICHIRO NAKAI
  • 依托单位:
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    3350万元
  • 批准年份:
    2019
  • 负责人:
    刘衍文
  • 依托单位:
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2018
  • 负责人:
    张里
  • 依托单位:
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究